Association Between Time to Initiation of Adjuvant Chemotherapy and Survival in Colorectal CancerJames Biagi, Christopher M. Booth, Michael J. Raphael et al.|JAMA|2011Cited by 632
A phase II and pharmacokinetic study of SB-715992, in patients with metastatic hepatocellular carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG IND.168)Jennifer J. Knox, Lesley Seymour, Sharlene Gill et al.|Investigational New Drugs|2008Cited by 67
Eastern Canadian Colorectal Cancer Consensus Conference: Setting the Limits of Resectable DiseaseMichael M. Vickers, Timothy R. Asmis, D. Jalink et al.|Current Oncology|2010Cited by 22
Eastern Canadian Colorectal Cancer Consensus Conference: Standards of Care for the Treatment of Patients with Rectal, Pancreatic, and Gastrointestinal Stromal Tumours and Pancreatic Neuroendocrine TumoursT. Di Valentin, Rachel Goodwin, James Biagi et al.|Current Oncology|2013Cited by 5
Health related quality of life in older or frail patients with advanced colorectal cancer treated with dose reduced capecitabineDaniel Breadner, Stephen Welch, Mark Vincent et al.|Journal of Geriatric Oncology|2018Cited by 4